Skip to main content
AAN.com
Commentary
January 20, 2022

Tackling Quality—It's Never a Level Playing Field
Companion Piece to the Neurology Outcome Measure Set

Abstract

The American Academy of Neurology (AAN) has recently proposed 3 outcome metrics crafted to be both broadly applicable across neurologic diseases and to function as potential tools to facilitate quality improvement. These measures should be of interest to physicians and payers due to the increasing linkage of reimbursement to quality care. However, the use of quality measures cannot exist in a vacuum as external factors outside of physician control can negatively affect these metrics. The original Centers for Medicare and Medicaid (CMS) value-based programs illustrate the necessity for iterative review and revision of outcome metrics to allow for risk adjustment to avoid unjust penalties. Accordingly, at this time, the Neurology Outcome Measurement Set is not suitable for inclusion in a quality payment program.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Porter ME, Teisberg EO. Redefining Health Care: Creating Value-Based Competition on Results. Harvard Business School Press, 2006.
2.
Centers for Medicare and Medicaid Services. National Health Expenditures 2017 Highlights. Accessed November 9, 2020. cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/downloads/highlights.pdf.
3.
Japsen B. UnitedHealth, Aetna, Anthem near 50% value-based care spending. Forbes 2017. Accessed November 9, 2020. forbes.com/sites/brucejapsen/2017/02/02/unitedhealth-aetna-anthem-near-50-value-based-care-spending/?sh=5a2fa951d4e2.
4.
Sico JJ, Sarwal A, Benish SM, et al. Quality improvement in neurology: neurology outcomes quality measurement Set. Neurology 2020;94(22):982-990.
5.
Centers of Medicare and Medicaid Services. Better Care. Smarter Spending. Healthier People: Paying Providers for Value, Not Volume. 2015, Jan 26. Accessed November 9, 2020. cms.gov/newsroom/fact-sheets/better-care-smarter-spending-healthier-people-paying-providers-value-not-volume#:∼:text=Better%20Care.-,Smarter%20Spending.,Providers%20for%20Value%2C%20Not%20Volume&text=Improving%20the%20quality%20and%20affordability,expanding%20access%20to%20such%20care. Better Care. Smarter Spending. Healthier People: Paying Providers for Value, Not Volume.
6.
Centers for Medicare and Medicaid Services. What are the value-based programs? Page last modified January 6, 2020. Accessed November 9, 2020. cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-Programs/Value-Based-Programs.
7.
Centers for Medicare and Medicaid Services. Hospital Readmissions Reduction Program (HRRP). Page last modified August 24, 2020. Accessed November 9, 2020. cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.
8.
NEJM catalyst. What is pay for performance in healthcare? 2018. Accessed November 9, 2020. catalyst.nejm.org/doi/full/10.1056/CAT.18.0245.
9.
Martsolf GR, Barrett ML, Weiss AJ, et al. Impact of race/ethnicity and socioeconomic status on risk-adjusted readmission rates: implications for the hospital readmissions reduction program. Inquiry 2016;53:0046958016667596.
10.
Centers for Medicare and Medicaid Services. The Hospital Value-Based Purchasing (VBP) Program. Page last modified 2020 Jan 6. Accessed November 9, 2020. cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-Programs/HVBP/Hospital-Value-Based-Purchasing.

Information & Authors

Information

Published In

Neurology® Clinical Practice
Volume 12Number 3June 2022
Pages: 270-272

Publication History

Received: June 3, 2021
Accepted: December 29, 2021
Published online: January 20, 2022
Published in print: June 2022

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Brian Cabaniss, MD
Emory University (BC), Atlanta, GA; Phoenix Children's Hospital (KW), Phoenix, AZ; Intermountain Medical Group (MW), Murray, UT; American Academy of Neurology (DC), Minneapolis, MN; and University of Colorado Anschutz Medical Campus (KN), Aurora, CO.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Role: Principal Investigator IRB00090291 Study Title: Stereotactic Laser Ablation for Temporal Lobe Epilepsy (SLATE) Principal Investigator: Brian T. Cabaniss 2020 - Present FTE: 2.5 - 5% Role: Principal Investigator United Health Sciences / Takeda / Emory EEG Earbud Study Title: EEG Earbude Principal Investigator: Brian T. Cabaniss 2019 - Present FTE: 5% Role: Co-investigator NINDS R21 (NS104953) Study Title: Novel Strategies for Mapping the Emotional Neural Circuitry Using Human Brain Stimulation Principal Investigator: Kelly Bijanki and Jon Willie 2018 – 2020 FTE: 5%
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Korwyn Williams, MD, PhD
Emory University (BC), Atlanta, GA; Phoenix Children's Hospital (KW), Phoenix, AZ; Intermountain Medical Group (MW), Murray, UT; American Academy of Neurology (DC), Minneapolis, MN; and University of Colorado Anschutz Medical Campus (KN), Aurora, CO.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
American Academy of Neurology for talks on coding.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Meghan Ward, MD
Emory University (BC), Atlanta, GA; Phoenix Children's Hospital (KW), Phoenix, AZ; Intermountain Medical Group (MW), Murray, UT; American Academy of Neurology (DC), Minneapolis, MN; and University of Colorado Anschutz Medical Campus (KN), Aurora, CO.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1) Compassionate Use Board, Utah Medical Cannabis Program, Utah Department of Health, (2) Utah Labor Commission, (3) RVS Update Committee (RUC), American Academy of Neurology
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Desiree Cremeen, MA
Emory University (BC), Atlanta, GA; Phoenix Children's Hospital (KW), Phoenix, AZ; Intermountain Medical Group (MW), Murray, UT; American Academy of Neurology (DC), Minneapolis, MN; and University of Colorado Anschutz Medical Campus (KN), Aurora, CO.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
American Academy of Neurology, Payer Relations and Coverage Program Manager, 2 years
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kavita Nair, PhD
Emory University (BC), Atlanta, GA; Phoenix Children's Hospital (KW), Phoenix, AZ; Intermountain Medical Group (MW), Murray, UT; American Academy of Neurology (DC), Minneapolis, MN; and University of Colorado Anschutz Medical Campus (KN), Aurora, CO.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Commercial or non profit entity American Academy of Neurology- Speaking honoraria and travel Consortium of Multiple Sclerosis Centers-Speaking honoraria and travel
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Commercial entity Bristol Meyers Squibb Novartis Genentech Biogen
Speakers' Bureaus:
1.
Commercial Sanofi Genzyme
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Commercial entity Novartis Genentech Alexion
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Cabaniss [email protected]
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Disclosure

B. Cabaniss reports no disclosures relevant to the manuscript. K. Williams has received honoraria for lectures on behalf of the American Academy of Neurology. M. Ward reports no disclosures relevant to the manuscript. D. Cremeen is employed by the American Academy of Neurology. K. Nair reports no disclosures relevant to the manuscript. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Study Funding

No targeted funding reported.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share